Delivery Order SPE2DR25D3101-SPE2DR26F6A01
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,551.65 to Amerisourcebergen Drug Corp for the supply of Emgality 120 mg/ml pen injectors, with an ultimate completion date of January 7, 2026. This competitively awarded, firm fixed-price order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical...
- The Defense Logistics Agency awarded a $7,113.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Emgality 120 mg/ml pen injectors. This is a non-set-aside competitive award with an ultimate completion date of January 27, 2026, to be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,719.39 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen injectors. This competitively awarded, firm fixed-price contract was issued on January 12, 2026, with an ultimate completion date of January 13, 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order executed under AmerisourceBergen's parent company...
- The Defense Logistics Agency awarded a $1,674 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors on January 8, 2026, with an ultimate completion date of January 9, 2026. This award was not set aside and represents a competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,231.14 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors, with an ultimate completion date of October 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a routine pharmaceutical supply transaction under the company's broader federal contract portfolio. The product will be delivered to the contracting office in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $2,273.90 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors, with an ultimate completion date of December 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the contractor's headquarters location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,404.08 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen injectors. This firm fixed price, competitively awarded contract was executed on September 16, 2025, with a completion deadline of September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized in this procurement action. This delivery order represents a...
- The Defense Logistics Agency awarded a $1,729.00 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement fulfilling...
- The Defense Logistics Agency awarded a delivery order valued at $11,329.50 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen injectors. This firm fixed-price, competitively awarded delivery order was issued on September 5, 2025, with an ultimate completion date of September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $1,506.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors on December 11, 2025, with an ultimate completion date of December 12, 2025. This is a non-set-aside competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F6A01Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,004.40 to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 26, 2026, for the supply of Emgality 120 mg/ml pen injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 27, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a task order under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor within the federal supply chain, delivering an extensive portfolio of brand-name and generic medications to support military healthcare systems worldwide. The parent company Cencora, Inc. maintains a significant single-award Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, which provides the contracting vehicle for this and similar pharmaceutical supply orders across multiple therapeutic domains. The contractor's competitively awarded delivery orders demonstrate its established capability to meet federal procurement requirements for specialized medications and medical supplies supporting military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 1/25/26 |